Smith Chas P & Associates Pa Cpas Novo Nordisk A S Transaction History
Smith Chas P & Associates Pa Cpas
- $1.78 Billion
- Q2 2025
A detailed history of Smith Chas P & Associates Pa Cpas transactions in Novo Nordisk A S stock. As of the latest transaction made, Smith Chas P & Associates Pa Cpas holds 197,466 shares of NVO stock, worth $9.83 Million. This represents 0.77% of its overall portfolio holdings.
Number of Shares
197,466
Previous 81,053
143.63%
Holding current value
$9.83 Million
Previous $5.63 Million
142.16%
% of portfolio
0.77%
Previous 0.33%
Shares
2 transactions
Others Institutions Holding NVO
# of Institutions
1,744Shares Held
337MCall Options Held
10.7MPut Options Held
16M-
Jennison Associates LLC18.9MShares$940 Million0.78% of portfolio
-
Bank Of America Corp Charlotte, NC14.8MShares$736 Million0.08% of portfolio
-
Loomis Sayles & CO L P12.4MShares$617 Million1.24% of portfolio
-
Morgan Stanley New York, NY12.3MShares$613 Million0.06% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa11.9MShares$591 Million0.36% of portfolio
About NOVO NORDISK A S
- Ticker NVO
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 2,257,289,984
- Market Cap $112B
- Description
- Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...